Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03591510
Title A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries USA | ITA | DEU | AUT

Facility Status City State Zip Country Details
Novartis Investigative Site WITHDRAWN Aurora Colorado 80045 United States Details
Novartis Investigative Site WITHDRAWN Miami Florida 33155 United States Details
Novartis Investigative Site RECRUITING Wien A 1090 Austria Details
Novartis Investigative Site RECRUITING Brno 613 00 Czechia Details
Novartis Investigative Site RECRUITING Praha 5 150 06 Czechia Details
Novartis Investigative Site RECRUITING Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site RECRUITING Berlin 13353 Germany Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Freiburg 79106 Germany Details
Novartis Investigative Site RECRUITING Halle 06120 Germany Details
Novartis Investigative Site WITHDRAWN Athens 115 27 Greece Details
Novartis Investigative Site RECRUITING Bologna BO 40138 Italy Details
Novartis Investigative Site RECRUITING Genova GE 16147 Italy Details
Novartis Investigative Site RECRUITING Monza MB 20900 Italy Details
Novartis Investigative Site RECRUITING Padova PD 35128 Italy Details
Novartis Investigative Site RECRUITING Pavia PV 27100 Italy Details
Novartis Investigative Site RECRUITING Roma RM 00165 Italy Details
Novartis Investigative Site RECRUITING Torino TO 10126 Italy Details
Novartis Investigative Site RECRUITING Napoli 80100 Italy Details
Novartis Investigative Site WITHDRAWN Kobe-city Hyogo 650-0047 Japan Details
Novartis Investigative Site WITHDRAWN Setagaya-ku Tokyo 157-8535 Japan Details
Novartis Investigative Site COMPLETED Osaka 534-0021 Japan Details
Novartis Investigative Site WITHDRAWN Saitama 330 8777 Japan Details
Novartis Investigative Site RECRUITING Shizuoka 420 8660 Japan Details
Novartis Investigative Site RECRUITING Amman 11941 Jordan Details
Novartis Investigative Site RECRUITING Seoul 03080 Korea, Republic of Details
Novartis Investigative Site RECRUITING Seoul 05505 Korea, Republic of Details
Novartis Investigative Site RECRUITING Gdansk 80 952 Poland Details
Novartis Investigative Site RECRUITING Krakow 30-663 Poland Details
Novartis Investigative Site WITHDRAWN Ekaterinburg 620149 Russian Federation Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Moscow 117198 Russian Federation Details
Novartis Investigative Site RECRUITING Ljubljana 1000 Slovenia Details
Novartis Investigative Site RECRUITING Adana 1330 Turkey Details
Novartis Investigative Site RECRUITING Antalya 07070 Turkey Details
Novartis Investigative Site RECRUITING Istanbul 34093 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field